IL10 and dermatitis: These results suggested that augmented Th17 responses and reduced IL-10 expression had a greater impact on the psoriasis-like skin inflammation than the abrogated type I interferon and inflammatory cytokine responses in the IRF5 KO mice, resulting in the exacerbation of clinical symptoms and histochemical changes.